Viral Load and Immune Monitoring
Improve the odds of posttransplant success
Despite advances in transplantation care, infection remains the main cause of posttransplant mortality. Only QIAGEN can enable a more complete clinical picture to improve the odds for transplant recipients. We enable physicians to accurately detect patient infections using artus viral load assays, and we offer novel solutions to assess transplant patients' immune responses with QuantiFERON Monitor and QuantiFERON-CMV. With a more complete clinical picture, physicians can individualize posttransplant management and advance patient care.
See our portfolio
Detect infection with artus viral load assays
QIAGEN artus viral load assays enable transplant physicians to detect posttransplant infections. The artus portfolio includes fully automated solutions for detection of BKV, CMV, EBV, HSV, and VZV on the QIAsymphony RGQ. We also have newly released artus kits for the quantitative detection of HAdV, HHV6, HSV, and JCV on Rotor-gene Q instruments.
View artus assays
Assess immunity with QuantiFERON Monitor and QuantiFERON-CMV
QuantiFERON Monitor is the only assay available to assess an individual’s cell-mediated immune response through dual innate and adaptive immune system stimulation, providing qualitative analysis of cell-mediated immunity.
Find out more about QFM.
QuantiFERON-CMV is a test to monitor a patient’s level of anti-CMV immunity. Loss of this immune function may be associated with the development of CMV disease. Testing with QuantiFERON-CMV and artus CMV PCR Kits can provide clinicians with greater confidence in managing high-risk CMV patients.
Find out more about QF-CMV.
Find out more about QFM.
QuantiFERON-CMV is a test to monitor a patient’s level of anti-CMV immunity. Loss of this immune function may be associated with the development of CMV disease. Testing with QuantiFERON-CMV and artus CMV PCR Kits can provide clinicians with greater confidence in managing high-risk CMV patients.
Find out more about QF-CMV.
Learn how our portfolio can save lives
Dr. Tiziana Lazzarotto and Dr. Luciano Potena are passionate about their transplant patients. At the University of Bologna, they use QIAGEN’s artus viral load assays to measure viral infection and QuantiFERON-CMV to measure patients' immune response to CMV infection.
“Our task is to prevent the progression of a viral infection towards active disease. So if we diagnose an infection and see only a poor immune response to it, we need to help the patient by either reducing the immunosuppressant or initiating an antiviral therapy.”
“Our task is to prevent the progression of a viral infection towards active disease. So if we diagnose an infection and see only a poor immune response to it, we need to help the patient by either reducing the immunosuppressant or initiating an antiviral therapy.”